These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30099725)

  • 61. HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation.
    Arosio A; Cristofani R; Pansarasa O; Crippa V; Riva C; Sirtori R; Rodriguez-Menendez V; Riva N; Gerardi F; Lunetta C; Cereda C; Poletti A; Ferrarese C; Tremolizzo L; Sala G
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):51-62. PubMed ID: 31663379
    [No Abstract]   [Full Text] [Related]  

  • 62. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis.
    Sumi H; Kato S; Mochimaru Y; Fujimura H; Etoh M; Sakoda S
    J Neuropathol Exp Neurol; 2009 Jan; 68(1):37-47. PubMed ID: 19104447
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neurodegenerative Disease-Associated TDP-43 Fragments Are Extracellularly Secreted with CASA Complex Proteins.
    Casarotto E; Sproviero D; Corridori E; Gagliani MC; Cozzi M; Chierichetti M; Cristofani R; Ferrari V; Galbiati M; Mina F; Piccolella M; Rusmini P; Tedesco B; Gagliardi S; Cortese K; Cereda C; Poletti A; Crippa V
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159325
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis.
    Dayton RD; Gitcho MA; Orchard EA; Wilson JD; Wang DB; Cain CD; Johnson JA; Zhang YJ; Petrucelli L; Mathis JM; Klein RL
    Mol Ther; 2013 Jul; 21(7):1324-34. PubMed ID: 23689600
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS.
    Mitchell JC; Constable R; So E; Vance C; Scotter E; Glover L; Hortobagyi T; Arnold ES; Ling SC; McAlonis M; Da Cruz S; Polymenidou M; Tessarolo L; Cleveland DW; Shaw CE
    Acta Neuropathol Commun; 2015 Jun; 3():36. PubMed ID: 26108367
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions.
    Nishihira Y; Tan CF; Onodera O; Toyoshima Y; Yamada M; Morita T; Nishizawa M; Kakita A; Takahashi H
    Acta Neuropathol; 2008 Aug; 116(2):169-82. PubMed ID: 18481073
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
    Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.
    Igaz LM; Kwong LK; Lee EB; Chen-Plotkin A; Swanson E; Unger T; Malunda J; Xu Y; Winton MJ; Trojanowski JQ; Lee VM
    J Clin Invest; 2011 Feb; 121(2):726-38. PubMed ID: 21206091
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinical and pathological spectrum of TDP-43 associated ALS].
    Onodera O; Yokoseki A; Tan CF; Ishihara T; Nishiira Y; Toyoshima Y; Kakita A; Nishizawa M; Takahashi H
    Rinsho Shinkeigaku; 2010 Nov; 50(11):940-2. PubMed ID: 21921519
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region.
    Budini M; Buratti E; Stuani C; Guarnaccia C; Romano V; De Conti L; Baralle FE
    J Biol Chem; 2012 Mar; 287(10):7512-25. PubMed ID: 22235134
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

  • 73. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
    Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C
    Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characteristic Features of FUS Inclusions in Spinal Motor Neurons of Sporadic Amyotrophic Lateral Sclerosis.
    Ikenaka K; Ishigaki S; Iguchi Y; Kawai K; Fujioka Y; Yokoi S; Abdelhamid RF; Nagano S; Mochizuki H; Katsuno M; Sobue G
    J Neuropathol Exp Neurol; 2020 Apr; 79(4):370-377. PubMed ID: 32142134
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Hasegawa M; Arai T; Nonaka T; Kametani F; Yoshida M; Hashizume Y; Beach TG; Buratti E; Baralle F; Morita M; Nakano I; Oda T; Tsuchiya K; Akiyama H
    Ann Neurol; 2008 Jul; 64(1):60-70. PubMed ID: 18546284
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
    Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
    Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis.
    Sanelli T; Xiao S; Horne P; Bilbao J; Zinman L; Robertson J
    J Neuropathol Exp Neurol; 2007 Dec; 66(12):1147-53. PubMed ID: 18090923
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rho guanine nucleotide exchange factor is an NFL mRNA destabilizing factor that forms cytoplasmic inclusions in amyotrophic lateral sclerosis.
    Droppelmann CA; Keller BA; Campos-Melo D; Volkening K; Strong MJ
    Neurobiol Aging; 2013 Jan; 34(1):248-62. PubMed ID: 22835604
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Amyotrophic lateral sclerosis of long clinical course clinically presenting with progressive muscular atrophy.
    Matsubara T; Oda M; Takahashi T; Watanabe C; Tachiyama Y; Morino H; Kawakami H; Kaji R; Maruyama H; Murayama S; Izumi Y
    Neuropathology; 2019 Feb; 39(1):47-53. PubMed ID: 30511354
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains.
    Seyfried NT; Gozal YM; Dammer EB; Xia Q; Duong DM; Cheng D; Lah JJ; Levey AI; Peng J
    Mol Cell Proteomics; 2010 Apr; 9(4):705-18. PubMed ID: 20047951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.